Log In
Print
BCIQ
Print
Print this Print this
 

zoptarelin doxorubicin acetate (AEZS-108) (formerly AN-152, ZEN-008)

  Manage Alerts
Collapse Summary General Information
Company Aeterna Zentaris Inc.
DescriptionDoxorubicin chemotherapeutic conjugated to luteinizing hormone-releasing hormone (LHRH) receptor agonist
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

0

$1.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today